ONEMEDNET CORPORATION Operating Expenses
ONEMEDNET CORPORATION (ONMD) reported Operating Expenses of $1.70 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- ONEMEDNET CORPORATION operating expenses for the quarter ending 2026-06-30 was $1.70M, a 6.92% decline year-over-year.
- ONEMEDNET CORPORATION operating expenses for the quarter ending 2026-03-31 was $2.17M, a 8.60% increase year-over-year.
- ONEMEDNET CORPORATION operating expenses for the quarter ending 2025-12-31 was $3.25M, a 20.71% increase year-over-year.
- ONEMEDNET CORPORATION operating expenses for the quarter ending 2025-09-30 was $2.01M, a 10.61% decline year-over-year.
- ONEMEDNET CORPORATION operating expenses for fiscal 2023 was $6.72M, a 8.58% decline from fiscal 2022.
- ONEMEDNET CORPORATION operating expenses for fiscal 2022 was $7.36M.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.70M 10-Q · filed 2026-08-14 | $3.66M 10-Q · filed 2026-08-14 | $7.12M derived: sum of 3 quarters · filed 2026-08-14 | $9.13M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $2.17M S-1/A · filed 2026-07-08 | $5.42M derived: sum of 2 quarters · filed 2026-07-08 | $7.43M derived: sum of 3 quarters · filed 2026-07-08 | $9.25M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $3.25M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $5.26M derived: sum of 2 quarters · filed 2026-07-08 | $7.08M derived: sum of 3 quarters · filed 2026-08-14 | $9.16M S-1/A · filed 2026-07-08 | |||
| 2025-09-30 | $2.01M 10-Q · filed 2025-11-14 | $3.83M derived: sum of 2 quarters · filed 2026-08-14 | $5.92M 10-Q · filed 2025-11-14 | $8.53M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $1.82M 10-Q · filed 2026-08-14 | $3.91M 10-Q · filed 2026-08-14 | $6.51M derived: sum of 3 quarters · filed 2026-08-14 | $8.76M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | $2.00M S-1/A · filed 2026-07-08 | $4.69M derived: sum of 2 quarters · filed 2026-07-08 | $6.94M derived: sum of 3 quarters · filed 2026-07-08 | $9.29M derived: sum of 4 quarters · filed 2026-07-08 | |||
| 2024-12-31 | $2.69M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | $4.94M derived: sum of 2 quarters · filed 2026-07-08 | $7.29M derived: sum of 3 quarters · filed 2026-07-08 | $9.32M S-1/A · filed 2026-07-08 | |||
| 2024-09-30 | $2.25M 10-Q · filed 2025-11-14 | $2.30M 10-Q · filed 2024-12-17 | $4.60M derived: sum of 2 quarters · filed 2025-11-14 | $6.63M 10-Q · filed 2025-11-14 | $6.68M 10-Q · filed 2024-12-17 | $8.51M derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $2.35M 10-Q · filed 2025-08-13 | $4.38M 10-Q · filed 2025-08-13 | $6.25M derived: sum of 3 quarters · filed 2025-08-13 | $8.21M derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $2.03M 10-Q · filed 2025-05-14 | $3.90M derived: sum of 2 quarters · filed 2025-05-14 | $5.86M derived: sum of 3 quarters · filed 2025-05-14 | $7.38M derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $3.83M derived: sum of 2 quarters · filed 2025-04-15 | $5.34M derived: sum of 3 quarters · filed 2025-04-15 | $6.72M 10-K · filed 2025-04-15 | $8.25M 10-K · filed 2024-04-09 | ||
| 2023-09-30 | $1.96M 10-Q · filed 2024-12-17 | $1.96M 8-K/A · filed 2024-11-22 | $3.47M derived: sum of 2 quarters · filed 2024-12-17 | $4.85M 10-Q · filed 2024-12-17 | $4.28M 10-Q · filed 2023-11-20 | $6.58M derived: sum of 4 quarters · filed 2024-12-17 | |
| 2023-06-30 | $1.51M 10-Q · filed 2024-12-11 | $2.90M 10-Q · filed 2024-12-11 | $4.62M derived: sum of 3 quarters · filed 2024-12-11 | $7.46M derived: sum of 4 quarters · filed 2024-12-11 | |||
| 2023-03-31 | $1.38M 10-Q · filed 2024-12-05 | $3.11M derived: sum of 2 quarters · filed 2024-12-05 | $5.95M derived: sum of 3 quarters · filed 2024-12-05 | ||||
| 2022-12-31 | $1.73M derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | $4.57M derived: sum of 2 quarters · filed 2024-11-22 | $7.36M 10-K/A · filed 2024-11-05 | $11.06M 10-K · filed 2024-04-09 | |||
| 2022-09-30 | $2.84M 8-K/A · filed 2024-11-22 | $5.63M 8-K/A · filed 2024-11-22 | $3.54M 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |